{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:51:02Z","timestamp":1790743862023,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Hacettepe University Scientific Research Projects Coordination Unit","award":["014 D04 101 012-575"],"award-info":[{"award-number":["014 D04 101 012-575"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00296-020-04735-w","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T17:02:51Z","timestamp":1603731771000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inflammatory milieu of muscle biopsies in juvenile dermatomyositis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6542-2656","authenticated-orcid":false,"given":"Erdal","family":"Sag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsev","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goknur","family":"Haliloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelda","family":"Bilginer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhal","family":"Akcoren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diclehan","family":"Orhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safak","family":"Gucer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"Topaloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beril","family":"Talim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"issue":"5","key":"4735_CR1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.berh.2009.07.007","volume":"23","author":"LR Wedderburn","year":"2009","unstructured":"Wedderburn LR, Rider LG (2009) Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol 23(5):665\u2013678","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4735_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-0029-1206170","volume":"17","author":"H Unverricht","year":"1891","unstructured":"Unverricht H (1891) Dermatomyositis acuta. DTsch Med Wochenschr 17:41\u201344","journal-title":"DTsch Med Wochenschr"},{"issue":"8","key":"4735_CR3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975a) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u2013407","journal-title":"N Engl J Med"},{"issue":"7","key":"4735_CR4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975b) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347","journal-title":"N Engl J Med"},{"issue":"11","key":"4735_CR5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrrheum.2011.139","volume":"7","author":"AB Robinson","year":"2011","unstructured":"Robinson AB, Reed AM (2011) Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol 7(11):664\u2013675","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"4735_CR6","first-page":"605","volume":"31","author":"CK Li","year":"2004","unstructured":"Li CK et al (2004) MHC Class I overexpression on muscles in early juvenile dermatomyositis. J Rheumatol 31(3):605\u2013609","journal-title":"J Rheumatol"},{"issue":"1\u20132","key":"4735_CR7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00032-8","volume":"137","author":"G Chevrel","year":"2003","unstructured":"Chevrel G et al (2003) Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol 137(1\u20132):125\u2013133","journal-title":"J Neuroimmunol"},{"issue":"5","key":"4735_CR8","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.22558","volume":"56","author":"CML de Padilla","year":"2007","unstructured":"de Padilla CML et al (2007) Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum 56(5):1658\u20131668","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4735_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/ar3531","volume":"13","author":"EC Baechler","year":"2011","unstructured":"Baechler EC, Bilgic H, Reed AM (2011) Type I interferon pathway in adult and juvenile dermatomyositis. Arthritis Res Ther 13(6):249","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"4735_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11926-011-0166-x","volume":"13","author":"L Kao","year":"2011","unstructured":"Kao L, Chung L, Fiorentino DF (2011) Pathogenesis of dermatomyositis: role of cytokines and interferon. Curr Rheumatol Rep 13(3):225\u2013232","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"4735_CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08916930600622256","volume":"39","author":"S Salomonsson","year":"2006","unstructured":"Salomonsson S, Lundberg IE (2006) Cytokines in idiopathic inflammatory myopathies. Autoimmunity 39(3):177\u2013190","journal-title":"Autoimmunity"},{"issue":"5","key":"4735_CR12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","volume":"40","author":"I Lundberg","year":"1997","unstructured":"Lundberg I et al (1997) Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 40(5):865\u2013874","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4735_CR13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/nan.12498","volume":"45","author":"S Soponkanaporn","year":"2019","unstructured":"Soponkanaporn S et al (2019) Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis. Neuropathol Appl Neurobiol 45(4):410\u2013420","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"4735_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3083.2010.02432.x","volume":"72","author":"A Jager","year":"2010","unstructured":"Jager A, Kuchroo VK (2010) Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 72(3):173\u2013184","journal-title":"Scand J Immunol"},{"issue":"1","key":"4735_CR15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ni.1802","volume":"11","author":"MT Palmer","year":"2010","unstructured":"Palmer MT, Weaver CT (2010) Autoimmunity: increasing suspects in the CD4+ T cell lineup. Nat Immunol 11(1):36\u201340","journal-title":"Nat Immunol"},{"issue":"1","key":"4735_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ni.1803","volume":"11","author":"L Steinman","year":"2010","unstructured":"Steinman L (2010) Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nat Immunol 11(1):41\u201344","journal-title":"Nat Immunol"},{"issue":"7","key":"4735_CR17","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.23012","volume":"57","author":"LR Wedderburn","year":"2007","unstructured":"Wedderburn LR et al (2007) International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 57(7):1192\u20131201","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4735_CR18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/annrheumdis-2013-203396","volume":"74","author":"H Varsani","year":"2015","unstructured":"Varsani H et al (2015) Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Ann Rheum Dis 74(1):204\u2013210","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"4735_CR19","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.39753","volume":"68","author":"CT Deakin","year":"2016","unstructured":"Deakin CT et al (2016) Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis. Arthritis Rheumatol 68(11):2806\u20132816","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"4735_CR20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/nan.12528","volume":"45","author":"SA Yasin","year":"2019","unstructured":"Yasin SA et al (2019) Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features. Neuropathol Appl Neurobiol 45(5):495\u2013512","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"4735_CR21","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar4600","volume":"16","author":"SL Tansley","year":"2014","unstructured":"Tansley SL et al (2014) Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther 16(4):R138","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"4735_CR22","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.24411","volume":"60","author":"CM Lopez De Padilla","year":"2009","unstructured":"Lopez De Padilla CM et al (2009) Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis. Arthritis Rheum 60(4):1160\u20131172","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4735_CR23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis CV et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65(2):314\u2013324","journal-title":"Arthritis Rheum"},{"issue":"7","key":"4735_CR24","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3899\/jrheum.101321","volume":"38","author":"B Bader-Meunier","year":"2011","unstructured":"Bader-Meunier B et al (2011) Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry. J Rheumatol 38(7):1436\u20131440","journal-title":"J Rheumatol"},{"issue":"2","key":"4735_CR25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","volume":"76","author":"F Bellutti Enders","year":"2017","unstructured":"Bellutti Enders F et al (2017) Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis 76(2):329\u2013340","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4735_CR26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.38270","volume":"66","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R et al (2014) Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis. Arthritis Rheumatol 66(3):740\u2013749","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"4735_CR27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Y Hamaguchi","year":"2011","unstructured":"Hamaguchi Y et al (2011) Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 147(4):391\u2013398","journal-title":"Arch Dermatol"},{"issue":"1","key":"4735_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","volume":"92","author":"M Shah","year":"2013","unstructured":"Shah M et al (2013) The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92(1):25\u201341","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"4735_CR29","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/art.22865","volume":"56","author":"KB Stone","year":"2007","unstructured":"Stone KB et al (2007) Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum 56(9):3125\u20133131","journal-title":"Arthritis Rheum"},{"issue":"11","key":"4735_CR30","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","volume":"60","author":"H Bilgic","year":"2009","unstructured":"Bilgic H et al (2009) Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum 60(11):3436\u20133446","journal-title":"Arthritis Rheum"},{"issue":"1\u20132","key":"4735_CR31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","volume":"13","author":"EC Baechler","year":"2007","unstructured":"Baechler EC et al (2007) An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med 13(1\u20132):59\u201368","journal-title":"Mol Med"},{"issue":"1","key":"4735_CR32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","volume":"67","author":"M Salajegheh","year":"2010","unstructured":"Salajegheh M et al (2010) Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann Neurol 67(1):53\u201363","journal-title":"Ann Neurol"},{"issue":"7","key":"4735_CR33","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/ard.2006.068858","volume":"66","author":"H Chinoy","year":"2007","unstructured":"Chinoy H et al (2007) Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK. Ann Rheum Dis 66(7):970\u2013973","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"4735_CR34","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/intimm\/12.9.1329","volume":"12","author":"M De Rossi","year":"2000","unstructured":"De Rossi M et al (2000) Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 12(9):1329\u20131335","journal-title":"Int Immunol"},{"issue":"11","key":"4735_CR35","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","volume":"183","author":"A Jager","year":"2009","unstructured":"Jager A et al (2009) Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 183(11):7169\u20137177","journal-title":"J Immunol"},{"issue":"7198","key":"4735_CR36","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","volume":"453","author":"E Bettelli","year":"2008","unstructured":"Bettelli E et al (2008) Induction and effector functions of T(H)17 cells. Nature 453(7198):1051\u20131057","journal-title":"Nature"},{"issue":"2","key":"4735_CR37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/acr2.1011","volume":"1","author":"CS Crowson","year":"2019","unstructured":"Crowson CS et al (2019) Interferon chemokine score and other cytokine measures track with changes in disease activity in patients with juvenile and adult dermatomyositis. ACR Open Rheumatol 1(2):83\u201389","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"4735_CR38","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","volume":"68","author":"LC Coates","year":"2016","unstructured":"Coates LC et al (2016) Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 68(5):1060\u20131071","journal-title":"Arthritis Rheumatol"},{"issue":"9906","key":"4735_CR39","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten D et al (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382(9906):1705\u20131713","journal-title":"Lancet"},{"issue":"7090","key":"4735_CR40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235\u2013238","journal-title":"Nature"},{"issue":"8","key":"4735_CR41","doi-asserted-by":"crossref","first-page":"e105353","DOI":"10.1371\/journal.pone.0105353","volume":"9","author":"Y Vercoulen","year":"2014","unstructured":"Vercoulen Y et al (2014) Increased presence of FOXP3+ regulatory T cells in inflamed muscle of patients with active juvenile dermatomyositis compared to peripheral blood. PLoS ONE 9(8):e105353","journal-title":"PLoS ONE"},{"issue":"1","key":"4735_CR42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/cei.12311","volume":"177","author":"T Fujiyama","year":"2014","unstructured":"Fujiyama T et al (2014) Preferential infiltration of interleukin-4-producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis. Clin Exp Immunol 177(1):110\u2013120","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"4735_CR43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0092-8674(03)00319-2","volume":"113","author":"V Horsley","year":"2003","unstructured":"Horsley V et al (2003) IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113(4):483\u2013494","journal-title":"Cell"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04735-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T16:42:14Z","timestamp":1696956134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04735-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4735"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04735-w","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"assertion":[{"value":"17 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by Hacettepe University Ethical Committee (GO 13\/582-30).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}